You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

MONISTAT 3 COMBINATION PACK (PREFILLED) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Monistat 3 Combination Pack (prefilled) patents expire, and what generic alternatives are available?

Monistat 3 Combination Pack (prefilled) is a drug marketed by Medtech Products and is included in one NDA.

The generic ingredient in MONISTAT 3 COMBINATION PACK (PREFILLED) is miconazole nitrate. There are twenty-eight drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Monistat 3 Combination Pack (prefilled)

A generic version of MONISTAT 3 COMBINATION PACK (PREFILLED) was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MONISTAT 3 COMBINATION PACK (PREFILLED)?
  • What are the global sales for MONISTAT 3 COMBINATION PACK (PREFILLED)?
  • What is Average Wholesale Price for MONISTAT 3 COMBINATION PACK (PREFILLED)?
Summary for MONISTAT 3 COMBINATION PACK (PREFILLED)
Drug patent expirations by year for MONISTAT 3 COMBINATION PACK (PREFILLED)

US Patents and Regulatory Information for MONISTAT 3 COMBINATION PACK (PREFILLED)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medtech Products MONISTAT 3 COMBINATION PACK (PREFILLED) miconazole nitrate CREAM;TOPICAL, VAGINAL 021261-001 Feb 2, 2001 OTC Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

MONISTAT 3 COMBINATION PACK (PREFILLED) Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for MONISTAT 3 Combination Pack (Prefilled)

Introduction to MONISTAT 3 Combination Pack

MONISTAT 3 Combination Pack is a widely recognized treatment for vaginal yeast infections, offering a convenient and effective 3-day treatment regimen. This product is part of the MONISTAT brand, which is well-established in the antifungal market.

Market Demand and Trends

Prevalence of Vaginal Yeast Infections

Vaginal yeast infections are common, affecting millions of women worldwide. The high prevalence of these infections drives a consistent demand for effective treatments like MONISTAT 3 Combination Pack. According to various health studies, approximately 75% of women will experience at least one vaginal yeast infection in their lifetime, ensuring a steady market demand[5].

Consumer Preferences

Consumers increasingly prefer convenient and easy-to-use treatments. The MONISTAT 3 Combination Pack, with its prefilled applicators and external itch relief cream, aligns well with these preferences. The product's design for nighttime use and the inclusion of itch relief cream enhance user comfort and satisfaction, contributing to its market appeal[1][2][4].

Competitive Landscape

Market Competitors

The antifungal market is competitive, with several brands offering similar treatments. However, MONISTAT 3 Combination Pack stands out due to its brand recognition, efficacy, and user-friendly design. Competitors include other over-the-counter (OTC) antifungal products, but MONISTAT's reputation and the specific formulation of its 3-day treatment give it a competitive edge[3].

Differentiation

The MONISTAT 3 Combination Pack differentiates itself through its combination of prefilled applicators and external itch relief cream. This comprehensive approach to treating both internal and external symptoms of yeast infections sets it apart from single-component treatments. The product's regular strength and fragrance-free formulation also cater to a wide range of users[1][2][4].

Financial Performance

Revenue and Sales

The financial performance of MONISTAT 3 Combination Pack is robust, driven by its popularity and the consistent demand for yeast infection treatments. While exact revenue figures are not publicly disclosed, the product's presence in major retail chains and online marketplaces indicates strong sales. The convenience and effectiveness of the product contribute to repeat purchases and positive word-of-mouth, further boosting sales[3].

Pricing Strategy

The pricing of MONISTAT 3 Combination Pack is competitive within the antifungal market. The product is generally priced in the mid-range, making it accessible to a broad consumer base. The value proposition of a 3-day treatment with additional itch relief cream justifies the pricing, making it an attractive option for consumers seeking a comprehensive solution[1][2][4].

Marketing and Distribution

Distribution Channels

MONISTAT 3 Combination Pack is widely available through various distribution channels, including major retail pharmacies, online marketplaces, and the company's official website. This broad distribution ensures that the product is easily accessible to consumers, contributing to its market success[3].

Marketing Strategies

The marketing strategy for MONISTAT 3 Combination Pack focuses on highlighting its convenience, efficacy, and comprehensive treatment approach. Advertising campaigns often target women who have experienced yeast infections, emphasizing the product's ease of use and quick relief. Educational content and partnerships with healthcare providers also play a crucial role in promoting the product and building trust among consumers[3].

Regulatory Environment

FDA Approval and Compliance

MONISTAT 3 Combination Pack is FDA-approved for the treatment of vaginal yeast infections. The product complies with all relevant regulatory requirements, ensuring safety and efficacy for consumers. Compliance with FDA guidelines is crucial for maintaining market presence and consumer trust[4][5].

Consumer Feedback and Satisfaction

User Experience

Consumer feedback on MONISTAT 3 Combination Pack is generally positive, with users appreciating the product's ease of use and effectiveness. The inclusion of external itch relief cream is particularly praised for providing comprehensive relief from symptoms. However, as with any medication, some users may experience side effects such as vulvovaginal burning or itching, though these are relatively rare[5].

Future Outlook

Market Growth

The antifungal market is expected to continue growing due to increasing awareness and the prevalence of fungal infections. MONISTAT 3 Combination Pack is well-positioned to benefit from this growth, given its established brand and effective treatment regimen. Innovations in packaging and formulation could further enhance the product's appeal and market share[3].

Competitive Challenges

Despite its strong market position, MONISTAT 3 Combination Pack faces ongoing competition from other antifungal products. To maintain its market share, the brand must continue to innovate and respond to consumer preferences. This could involve expanding product lines, improving formulations, or enhancing user experience through digital health solutions[3].

Key Takeaways

  • Market Demand: High prevalence of vaginal yeast infections ensures consistent demand.
  • Competitive Edge: Comprehensive treatment approach with prefilled applicators and external itch relief cream.
  • Financial Performance: Strong sales driven by brand recognition and product efficacy.
  • Marketing and Distribution: Broad distribution channels and targeted marketing strategies.
  • Regulatory Compliance: FDA-approved and compliant with safety and efficacy standards.
  • Consumer Feedback: Generally positive, with some rare side effects reported.

FAQs

Q: What is the active ingredient in MONISTAT 3 Combination Pack?

A: The active ingredient is miconazole nitrate, with 200 mg in each prefilled applicator and 2% in the external cream[1][2][4].

Q: How do I use MONISTAT 3 Combination Pack?

A: Use one prefilled applicator intravaginally at bedtime for three consecutive nights. Also, apply the external itch relief cream as needed[1][2][4].

Q: Can I use MONISTAT 3 Combination Pack if I have never had a vaginal yeast infection diagnosed by a doctor?

A: No, you should not use MONISTAT 3 Combination Pack without a prior diagnosis by a doctor[4].

Q: Are there any potential interactions with other medications?

A: Yes, if you are taking the prescription blood thinning medicine warfarin, you should consult a doctor before use due to potential bleeding or bruising risks[4].

Q: What are the common side effects of MONISTAT 3 Combination Pack?

A: Common side effects include vulvovaginal burning, itching, or irritation. Less common side effects may include cramping, headaches, hives, or skin rash[5].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.